Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CME Group Inc.

CME Group Inc. (CME) Stock Overview

Explore CME Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

CME●NASDAQ
Financial ServicesFinancial - Data & Stock Exchanges
$315.50
$0.37(0.12%)
U.S. Market opens in 0h 30m

CME Group Inc. (CME)

Meyka AI Score

Z

Key Financials

Market Cap112.9B
P/E Ratio25.83
EPS (TTM)$11.77
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$308.36
3 Months$286.49
1 Year Target$285.78

CME Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CME Group Inc. (NASDAQ: CME) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CME Group Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CME on the NASDAQ shows an RSI of 70.06, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $285.78 for the NASDAQ listing.

Key metrics behind CME Group Inc.'s NASDAQ-traded stock include a P/E ratio of 25.83 and a market capitalization of 112.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CME on the NASDAQ.

Price Performance (NASDAQ: CME)

1-Day Change
-0.12%
5-Day Change
3.89%
1-Month Change
13.80%
3-Month Change
20.34%
6-Month Change
10.41%
Year-to-Date (YTD) Change
15.53%
1-Year Change
12.85%
3-Year Change
45.34%
5-Year Change
40.32%
All-Time (Max) Change
3577.16%

Contact Information

https://www.cmegroup.com
312 930 1000
20 South Wacker Drive, Chicago, IL, 60606

Company Facts

38,750 Employees
IPO DateDec 6, 2002
CountryUS
Actively Trading

Frequently Asked Questions